These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5401669)

  • 21. The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies.
    Boulet LP; Gauvreau G; Boulay ME; O'Byrne P; Cockcroft DW;
    Allergy; 2007 Oct; 62(10):1101-10. PubMed ID: 17845579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and urine amino nitrogen and urinary amino acids during short-term treatment with prednisone.
    Widomska-Czekajska T; Miturzyńska-Stryjecka H; Rupniewska Z
    Pol Med J; 1970; 9(4):811-6. PubMed ID: 5477487
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chronic inflammation increases the risk of cardiovascular disease in patients with rheumatoid arthritis].
    Troelsen LN; Jacobsen S
    Ugeskr Laeger; 2006 Sep; 168(39):3304-8. PubMed ID: 17032593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between inflammation and symptoms in asthma.
    Tillie-Leblond I; Montani D; Crestani B; de Blic J; Humbert M; Tunon-de-Lara M; Magnan A; Roche N; Ostinelli J; Chanez P
    Allergy; 2009 Mar; 64(3):354-67. PubMed ID: 19210358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
    Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
    J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience with the clinical use of the national steroid preparation Solasodin].
    Leshchinskiĭ LA; Trusov VV; Pevchikh VV; Belosludtsev IA
    Vrach Delo; 1968 May; 5():47-50. PubMed ID: 5740455
    [No Abstract]   [Full Text] [Related]  

  • 27. [To the problem of the effect of hormone therapy (ACTH, prednisolone) on the protein composition of the blood].
    Pevchikh VV
    Ter Arkh; 1966 Mar; 38(3):109-12. PubMed ID: 4295800
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of glucocorticoid hormone therapy on certain indices of the blood coagulation system].
    Bokarev IN
    Ter Arkh; 1967 Feb; 39(2):70-2. PubMed ID: 5611693
    [No Abstract]   [Full Text] [Related]  

  • 29. Airway inflammation: an important marker of control for asthma guidelines?
    Stirling R
    J Allergy Clin Immunol; 2008 May; 121(5):1293; author reply 1293-4. PubMed ID: 18405957
    [No Abstract]   [Full Text] [Related]  

  • 30. The biochemistry of inflammation: rheumatoid arthritis and anti-inflammatory drugs.
    Weissmann G
    J Miss State Med Assoc; 1982 Mar; 23(3):66-73. PubMed ID: 7086894
    [No Abstract]   [Full Text] [Related]  

  • 31. Stratified medicine in inflammatory disorders: From theory to practice.
    Arron JR; Townsend MJ; Keir ME; Yaspan BL; Chan AC
    Clin Immunol; 2015 Nov; 161(1):11-22. PubMed ID: 25934386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sle-saccharides: a promising tool against inflammation].
    Renkonen R; Renkonen O
    Duodecim; 1996; 112(3):161-2. PubMed ID: 10590623
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of T cell cytokines in modulating joint inflammation in rheumatoid arthritis.
    Gerli R; Pitzalis C; Lunardi C
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):949-52. PubMed ID: 12455188
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach.
    Mroz RM; Noparlik J; Chyczewska E; Braszko JJ; Holownia A
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):453-60. PubMed ID: 18204158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the clinical and biological properties of the sodium salt of 6-methyl-prednisolone hemisuccinate].
    Scalabrino R; Curtarelli G
    Clin Ter; 1966 Jun; 37(6):491-501. PubMed ID: 5989917
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis].
    Ainsworth MA; Brynskov J
    Ugeskr Laeger; 2007 Feb; 169(9):789-91. PubMed ID: 17355841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rheumatoid disorders in Crohn disease and ulcerative colitis. Dominance of non-inflammatory factors].
    Mosebach S; Tromm A; Wittenborg A; May B
    Leber Magen Darm; 1995 Mar; 25(2):76, 79-85. PubMed ID: 7752802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis].
    Cervini C; Salaffi F; Peroni M
    Clin Ter; 1993 Jan; 142(1):3-18. PubMed ID: 8472508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rationale and practice of arterial treatment of inflammatory rheumatism. Bouillaud's disease (AAR) and rheumatoid polyarthritis (CEP)].
    Debray M
    Maroc Med; 1967 Jan; 47(498):27-35. PubMed ID: 5595776
    [No Abstract]   [Full Text] [Related]  

  • 40. Infliximab for the treatment of ulcerative colitis.
    Eshuis EJ; Bemelman WA; Stokkers PC
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):219-29. PubMed ID: 19485804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.